Invention Grant
- Patent Title: Formulation
-
Application No.: US17052435Application Date: 2019-05-03
-
Publication No.: US11596608B2Publication Date: 2023-03-07
- Inventor: Paul Alhadeff , Christine Dieterich Johansson , Peter Zerhouni , Wei Tian , Graeme William Andrew Hamilton Johnston
- Applicant: INDEX PHARMACEUTICALS AB
- Applicant Address: SE Solna
- Assignee: INDEX PHARMACEUTICALS AB
- Current Assignee: INDEX PHARMACEUTICALS AB
- Current Assignee Address: SE Solna
- Agency: Sheppard, Mullin, Richter & Hampton LLP
- Priority: GB1807312 20180503
- International Application: PCT/EP2019/061443 WO 20190503
- International Announcement: WO2019/211466 WO 20191107
- Main IPC: C07H21/04
- IPC: C07H21/04 ; A61K9/48 ; A61K9/00 ; A61K31/7125
Abstract:
The present invention relates a formulation and capsule suitable for oral administration. The invention further relates to the use of the formulation and capsule for treating inflammatory bowel diseases, for instance ulcerative colitis (UC) or Crohn's disease.
Public/Granted literature
- US20210338592A1 FORMULATION Public/Granted day:2021-11-04
Information query
